In a significant boost to rural economic development, the USAID Agriculture Growing Rural Opportunities Activity (AGRO) has successfully raised $1 billion to further its mission in Ukraine. Financed by the United States Agency for International Development (USAID) and implemented by Chemonics International, AGRO is dedicated to revitalizing Ukraine's agricultural sector, particularly in the wake of the ongoing humanitarian crisis caused by Russia's invasion. The funding aims to support small and medium-sized agricultural enterprises (MSMEs) across the most vulnerable rural communities, enhancing their productivity and market integration both locally and globally. Targeting key value chains such as fruits, vegetables, dairy, meat, and grains, AGRO is implementing a series of strategic projects designed to restore economic activity, rebuild supply chains, and bolster food security. Currently, AGRO reaches over 6,000 farmers—approximately 12% of the registered agricultural enterprises in Ukraine—enabling them to enhance their operations with improved access to grain drying, storage, processing facilities, and financing. By empowering these agricultural producers, AGRO plays a crucial role in the Agriculture Resilience Initiative (AGRI)-Ukraine, which seeks to strengthen agricultural production and drive exports in a time of global food supply crises. This funding not only addresses immediate food security concerns but also lays the groundwork for sustained economic recovery and resilience for the future. To learn more about how you can support this vital initiative, please visit www.usaid.gov/ukraine/agriculture-resilience-initiative-agri-ukraine.
USAID AGRO Ukraine Secures $1 Billion Investment for Rural Agricultural Development
Get the full USAID AGRO Ukraine company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Anveshan
We are a food-tech startup aiming to provide high quality deeply traceable food products. We leverage technologies based on image processing, spectroscopy, blockchain and IOT to provide the best quality food products made traditionally.
$12.7M Series b
today
Caseway
We are the only enterprise AI form platform that replaces internal R&D and manual workflows by building and maintaining fully integrated automation systems, aligned to your data, your processes, and your long-term success. For document-intensive, compliance-driven organizations in regulated industries like insurance, education, finance, healthcare, and government Compelling reason to buy: Who need AI and automation tailored to their unique forms, workflows, and security environment, without having to shoulder R&D risk or manage AI development internally Product category: Our product is an enterprise document form platform Key benefit: That delivers a fully integrated, continuously improving automation system, built and maintained by experts, without upfront AI build costs Key differentiation: Our product is custom-built for each client’s systems and documents, fully integrated and continuously improved through a long-term partnership model, we maintain, debug, adapt, and align incentives to make it work in the real world.
$1.5M Pre-seed
today
Kubera Health
Kubera’s mission is to power a payment ecosystem where contracts are honored, care is rewarded, and waste is eliminated. We deliver contract and payment intelligence that unifies policies, terms, and claims data into one trusted platform — helping healthcare organizations and their partners build fairer contracts, ensure payments flow as intended, and align incentives across the care ecosystem. As healthcare shifts toward new reimbursement models and risk-sharing arrangements, Kubera is building the payment-intelligence backbone that enables multiple parties to adapt faster, protect margins, and dedicate more resources to patient care.
$6.5M Seed
today
Psilera
Psilera is a biotechnology company founded by scientists dedicated to finding better therapeutics for neurological conditions like dementia, addiction, and mental health disorders. Since 2019, Psilera has been focused on early-stage drug discovery & development with a dynamic team of experts in synthetic chemistry, pharmacology, clinical development, and business development.
$8.8M Seed
today
Abstract
Abstract is a venture capital firm based in San Francisco with $1.5 billion in assets under management. We are sector-agnostic, focused on seed and early stage founders. Our reputation among founders is built on fierce loyalty, unparalleled connections, and a relentless drive to help them win.
$59.0M Series a
today